Last updated: January 14, 2026
2026–2029
1. Strategic Commitment
Invitrolize SA is committed to fostering an inclusive, diverse, and equitable work environment as a foundation for scientific excellence, innovation, and responsible research. As a developer of advanced human-relevant New Approach Methodologies (NAMs), we recognise that gender equality contributes directly to research quality, creativity, and regulatory alignment.
This Gender Equality Plan (GEP) fulfils Horizon Europe eligibility requirements. It is formally adopted, signed by top management, and published on the Invitrolize website. The plan applies for 2026–2029 and is subject to annual review.
Signed,
Prof. Dr. Arno Gutleb
Managing Director, Invitrolize GmbH
Date: 14.01.2026
2. Governance and Resources
Gender equality considerations are integrated into company strategy, recruitment, and research governance.
3. Monitoring and Data Collection
Invitrolize collects and reviews sex-disaggregated data annually, including:
An annual management review evaluates indicators and identifies corrective actions if gender imbalances are observed. The objective is to prevent structural disparities and ensure merit-based progression.
4. Training and Awareness
Invitrolize commits to:
Participation in awareness activities will be documented.
5. Key Thematic Areas and Targets
Work-Life Balance & Organisational Culture
Target: Maintain equitable retention rates across genders.
Gender Balance in Leadership
Target: Avoid structural gender imbalance as the company scales.
Recruitment & Career Progression
Target: No unjustified gender disparities in hiring or promotion outcomes.
Integration of the Gender Dimension in Research
Target: Strengthen scientific robustness and regulatory readiness.
Prevention of Gender-Based Violence and Harassment
Target: Ensure a safe and respectful workplace for all staff.
6. Review and Continuous Improvement
This GEP will be reviewed annually by management and updated as Invitrolize grows. Gender equality is recognised as an ongoing commitment embedded in the company’s innovation strategy and responsible research practices.